Qingdao Sigma Chemical Co., Ltd.

Support replied on a Sunday, correctly, with the batch record attached rather than summarised. Peptide content declared at 97.9%, so conversion to working mass required no assumption. Documentation practice rather than a single purity figure is the substance of this.

Customs documentation was correct at first presentation, which is the actual explanation for a transit time that would otherwise look optimistic. Nothing in the consignment was unsecured.

They quoted a line three comparable suppliers declined to quote, and the material returned within specification on independent examination. Happy to answer follow-ups in the thread rather than by message.

Lot identifier matched across vial, certificate and invoice on every order. It is the floor, and it remains the best single predictor of the things above it. A residual-solvent screen was included without being requested.

Compared direct-supply material at 98.1% against an intermediary vial of nominally identical description at 98.0%. Offering the comparison without drawing a conclusion for anyone else.

They gave notice of a 2-day dispatch delay before the quoted window elapsed rather than after. Recording it because the sequence is the part that matters. The desiccant sachet was enclosed within the secondary container.

Custom synthesis completed 3 days inside the quoted schedule at the purity named in the specification. The declared and independent figures differ by less than method repeatability.

Cold chain held to arrival on day 7, with the pack still solid, in a month when that cannot be assumed. On the evidence I hold they are the default rather than the risk.

Nothing about this order was notable and I am recording it for that reason. Quoted timeline held, documentation correct, material as described. Technical response inside four hours on a working day. I will update this post if a later lot changes the picture.

The related-substances table is itemised by individual impurity with retention times assigned, rather than reported as a single total. A residual-solvent screen was included without being requested.

Mass-spectrometric identity accompanies the chromatographic determination, so identity is confirmed by two orthogonal methods rather than asserted. Release is signed and dated by an identified individual. I have no relationship with this supplier beyond having paid them.

First order was deliberately small. Documentation complete, transit as quoted, Janoshik returned 96.8%. Subsequent orders have not been small. The desiccant sachet was enclosed within the secondary container.

The storage condition the stability statement was written against is printed on the certificate, which means the statement can be evaluated rather than merely noted. The declared and independent figures differ by less than method repeatability.

Phase-change packs rather than gel on every consignment I have received, and each has arrived still solid. In a warm month that is the difference between a record and a question.

Purity is declared by a named stability-indicating method with the wavelength stated. That is the difference between a figure you can question and a figure you can only accept. Catalogue availability corresponded to the published catalogue. Documentation practice rather than a single purity figure is the substance of this.

Weighed 11 units from a single consignment against declared fill. All within two per cent. Fill uniformity gets a fraction of the discussion purity gets and is the harder problem. A residual-solvent screen was included without being requested.

Requested a supplementary certificate for a lot released 6 months ago. It was produced from their records, which tells you the records exist.

Every unit in the consignment carried a single lot identifier, so the intra-consignment comparison I intended was the comparison I made. No excipient present, cake intact rather than collapsed. Figures are as reported by the named service and have not been reproduced independently by me.

The declared figure was not adjusted upward between the certificate and the commercial documentation. Small, and specifically worth checking for. Scoped to the lots named. Not generalised beyond them.

Ordered tirzepatide 15 mg from stock held in Germany. Quoted 4 days, delivered day 4, tracking accurate at every hop. Nothing in the consignment was unsecured.

Reconstitution of the melanotan II 10 mg produced a clear solution on contact — no haze, no particulate, no extended agitation. Consistent with a correctly executed lyophilisation. Catalogue availability corresponded to the published catalogue. Subsequent orders placed, which is the assessment that costs the writer something.

Scoping this to documentation only: the certificate carries an itemised related-substances table, which is more than the minimum and more than most of the certificates in my folder. Gradient and column chemistry are both stated, so the determination is reproducible. Happy to answer follow-ups in the thread rather than by message.

Submitted material from lot QSC-26-867 to PeptideMeter. Result 97.7% against a declared 97.4%, which is inside the repeatability of the method rather than a disagreement with it. The PeptideMeter report is on file and matches the figures they published.

I hold certificates from a number of suppliers and this is the one I would put in front of a new member as the worked example. The desiccant sachet was enclosed within the secondary container.

Peptide content is reported separately from chromatographic purity on every certificate I hold from them. Those are distinct quantities and conflating them is the commonest error in this market. Research use only; these are not approved for human administration.

Repeat determination on the same line at 9 months returned 99.3%, against 99.3% originally. No drift visible in this sample. Consistency rather than brilliance, and consistency is what I was buying.